Literature DB >> 8708945

Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge.

A I Dongari-Bagtzoglou1, J L Ebersole.   

Abstract

Bacteria can indirectly affect the course of periodontal diseases by activating host cells to produce and release inflammatory mediators and cytokines. These mediators and cytokines manifest potent proinflammatory and catabolic activity and may play key roles in local amplification of the immune response as well as in periodontal tissue breakdown. This study tested the effect of Actinobacillus actinomycetemcomitans (Aa) and Campylobacter rectus (Cr) challenge on PGE2, IL-1 beta, IL-6 and IL-8 production by human gingival fibroblasts (HGF). Contact-inhibited HGF were prepared and formalin-killed bacterial cells (Aa JP2, ATCC 29523 & 33384 and Cr ATCC 33238) at 10(6)-10(9) were added to the HGF. Culture supernatants were collected at varying time intervals and analyzed for cytokine and mediator content. All concentrations of Aa JP2 and Cr ATCC 33238 suppressed IL-1 beta production up to approximately 50% during the initial 3-12-h period. No bacterial concentration tested was able to increase IL-1 beta production above the maximum basal levels. Both bacterial species stimulated production of IL-6 and IL-8. Aa JP2 did not affect PGE2 levels significantly, whereas Cr ATCC 33238 was stimulatory only at the highest concentration tested (10(9)). There were no significant differences among the three Aa strains with respect to IL-1 beta production. However, Aa ATCC 29523 and ATCC 33384 were less capable of stimulating IL-6 secretion and more efficient in stimulating IL-8 production than Aa JP2. In general, Cr was the most potent enhancer of cytokine and mediator production by HGF. In conclusion, Aa and Cr are capable of amplifying the local immune response and promoting periodontal tissue inflammation by stimulating HGF to secrete mainly IL-6 and IL-8.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708945     DOI: 10.1111/j.1600-0765.1996.tb00469.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  20 in total

Review 1.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Possible lethal enhancement of toxins from putative periodontopathogens by nicotine: implications for periodontal disease.

Authors:  N M Sayers; B P Gomes; D B Drucker; A S Blinkhorn
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

3.  Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis.

Authors:  Ricardo P Teles; Lauren C Gursky; Marcelo Faveri; Edvaldo A Rosa; Flavia R F Teles; Magda Feres; Sigmund S Socransky; Anne D Haffajee
Journal:  J Clin Periodontol       Date:  2010-04       Impact factor: 8.728

Review 4.  Campylobacter surface-layers (S-layers) and immune evasion.

Authors:  Stuart A Thompson
Journal:  Ann Periodontol       Date:  2002-12

5.  Luteolin and fisetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in human gingival fibroblasts.

Authors:  Gloria Gutiérrez-Venegas; Anabel Contreras-Sánchez
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

6.  Biological characterization of lipopolysaccharide from Treponema pectinovorum.

Authors:  Lakshmyya Kesavalu; Clinton W Falk; Kenneth J Davis; Michelle J Steffen; Xiaoping Xu; Stanley C Holt; Jeffrey L Ebersole
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Use of defined mutants to assess the role of the Campylobacter rectus S-layer in bacterium-epithelial cell interactions.

Authors:  B Wang; E Kraig; D Kolodrubetz
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis.

Authors:  S Akifusa; S Poole; J Lewthwaite; B Henderson; S P Nair
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts.

Authors:  C M Gelbmann; S N Leeb; D Vogl; M Maendel; H Herfarth; J Schölmerich; W Falk; G Rogler
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

10.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.